[Click here to register for ST&R’s July 25 webinar on FDA regulation of cosmetics and drug products.]
Food and Drug Administration import alerts on the following have been modified in the past week.
- processed human and animal foods
- raw agricultural products
- foods containing illegal and/or undeclared colors
- aquaculture seafood products
- medical devices from firms that have not met device quality system requirements
- imported food products that appear to be misbranded
- drugs from firms that have not met drug good manufacturing practices
- stevia leaves, crude extracts of stevia leaves, and foods containing stevia leaves and/or stevia extracts
- medical instruments from Pakistan
- cosmetics that are adulterated and/or misbranded due to color additive violations
- seafood products
- products from Japan due to radionuclide contamination
Importers of FDA-regulated goods are responsible for ensuring that such imports are in compliance with FDA laws and regulations. Before shipping into the U.S., importers should be aware of whether or not their product is listed on an import alert.
Import alerts inform FDA field staff that the agency has enough evidence or other information to allow a product that appears to be in violation of FDA laws and regulations to be detained without physical examination at the time of entry. Import alerts may cover products from designated countries or areas (including from all foreign countries), manufacturers, or shippers.
Firms and/or products on the “red list” of an import alert are subject to DWPE, while firms and/or products on the “green list” are not because they have met the criteria for exclusion. Some import alerts include a “yellow list” of firms, products, and/or countries subject to intensified surveillance because the nature of the violations may warrant further field examinations of individual entries and/or additional analyses. In addition, depending on the specific import alert, shipments of products subject to DWPE may still be imported into the U.S. if the importer has demonstrated that the shipment is in compliance.
If a product is detained without physical examination the importer has the right to provide evidence to the FDA in an attempt to overcome the appearance of the violation. If no such evidence is submitted, or if the evidence provided is insufficient to overcome the appearance of the violation, the product will be subject to refusal of entry into the U.S.
Copyright © 2021 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.